I've had a look and purchased a small holding for the time being
At the issue price it was priced at 17x FY15 NPATA and 26.5x FY15 NPAT. The amortisation is of acquired intangibles so the NPATA number is what I'm looking at. 16% and 21% growth forecast in FY15 for EBITDA and NPATA respectively. ROE is high although debt/equity is 132%. But Debt/EBITDA is manageable at 1.7x
Ann: Admission to Official List, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)